Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q13546: Variant p.Asp324Tyr

Receptor-interacting serine/threonine-protein kinase 1
Gene: RIPK1
Feedback?
Variant information Variant position: help 324 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Aspartate (D) to Tyrosine (Y) at position 324 (D324Y, p.Asp324Tyr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (D) to large size and aromatic (Y) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In AIEFL; prevents cleavage by CASP8; changed inflammatory response. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 324 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 671 The length of the canonical sequence.
Location on the sequence: help LKKEYSNENAVVKRMQSLQL D CVAVPSSRSNSATEQPGSLH The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         LKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLH

Mouse                         LKKEYPDQSPVLQRMFSLQHDCVPLPPSRSNS--EQPGSLH
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 671 Receptor-interacting serine/threonine-protein kinase 1
Region 290 – 582 Interaction with SQSTM1
Site 324 – 325 Cleavage; by CASP8
Modified residue 320 – 320 Phosphoserine; by MAP3K7
Modified residue 331 – 331 Phosphoserine; by MAP3K7
Modified residue 333 – 333 Phosphoserine; by MAP3K7
Mutagenesis 324 – 324 D -> K. Abolishes cleavage by caspase-8.



Literature citations
Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease.
Lalaoui N.; Boyden S.E.; Oda H.; Wood G.M.; Stone D.L.; Chau D.; Liu L.; Stoffels M.; Kratina T.; Lawlor K.E.; Zaal K.J.M.; Hoffmann P.M.; Etemadi N.; Shield-Artin K.; Biben C.; Tsai W.L.; Blake M.D.; Kuehn H.S.; Yang D.; Anderton H.; Silke N.; Wachsmuth L.; Zheng L.; Moura N.S.; Beck D.B.; Gutierrez-Cruz G.; Ombrello A.K.; Pinto-Patarroyo G.P.; Kueh A.J.; Herold M.J.; Hall C.; Wang H.; Chae J.J.; Dmitrieva N.I.; McKenzie M.; Light A.; Barham B.K.; Jones A.; Romeo T.M.; Zhou Q.; Aksentijevich I.; Mullikin J.C.; Gross A.J.; Shum A.K.; Hawkins E.D.; Masters S.L.; Lenardo M.J.; Boehm M.; Rosenzweig S.D.; Pasparakis M.; Voss A.K.; Gadina M.; Kastner D.L.; Silke J.;
Nature 577:103-108(2020)
Cited for: INVOLVEMENT IN AIEFL; VARIANTS AIEFL ASN-324; HIS-324 AND TYR-324; CHARACTERIZATION OF VARIANTS AIEFL ASN-324; HIS-324 AND TYR-324; CLEAVAGE BY CASP8; FUNCTION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.